Balance Sheet for Ionis Pharmaceuticals Inc. (IONS)

$ 60.775   -0.015 (-0.02%) Volume: 955.25k 4:00 PM EDT 6-Jul-2020
After Hours:  $ 60.78   0.005 (+0.01%) Volume: 178.29k 4:41 PM EDT 6-Jul-2020
Statement: View:
Assets [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 683 279 130 85 129
Restrictable Cash - - - - -
Marketable Securities 1,816 1,805 893 581 675
Accounts Receivable 63 13 63 108 11
Loans Receivable - - - - -
Other Receivables 63 13 63 108 11
Receivables 63 13 63 108 11
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other 18 9 10 7 7
Inventories, Adjustments & Allowances - - - - -
Inventories 18 9 10 7 7
Prepaid Expenses - - - - -
Current Deferred Income Taxes - - - - -
Other Current Assets 140 102 73 17 15
Total Current Assets 2,721 2,208 1,169 798 837
Land and Improvements 26 17 17 13 13
Buildings and Improvement 133 117 120 91 87
Machinery, Furniture and Equipment 68 60 73 69 63
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 228 194 210 173 163
Gross Fixed Assets 228 194 210 173 163
Accumulated Depreciation (74) (61) (88) (80) (73)
Net Fixed Assets 154 132 122 93 90
Intangibles 26 24 22 20 19
Cost in Excess - - - - -
Non-Current Deferred Income Taxes 306 291 - - -
Other Non-Current Assets 358 328 32 22 29
Total Non-Current Assets 513 460 154 115 111
Total Assets 3,233 2,668 1,323 912 948
Liabilities [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 16 29 25 21 28
Short Term Debt 2 14 2 1 9
Notes Payable - - - - -
Accrued Expenses 67 48 67 36 28
Accrued Liabilities 67 48 67 36 28
Deferred Revenues 118 160 125 51 67
Current Deferred Income Taxes (7) (291) - - -
Other Current Liabilities 70 30 25 24 16
Total Current Liabilities 273 280 244 134 149
Long Term Debt 786 633 606 588 464
Deferred Income Tax 490 567 108 91 134
Other Non-Current Liabilities 490 567 108 91 134
Minority Interest 213 139 84 - -
Capital Lease Obligations - - - 72 72
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 1,489 1,339 798 679 598
Total Liabilities 1,762 1,620 1,042 813 747
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 1,471 1,048 281 100 201
Common Par 0 0 0 0 0
Additional Paid in Capital 2,204 2,047 1,554 1,311 1,309
Cumulative Translation Adjustments - - - - -
Retained Earnings (708) (967) (1,241) (1,181) (1,095)
Treasury Stock - - - - -
Other Equity Adjustments (25) (32) (32) (30) (14)
Total Capitalization 2,257 1,681 887 615 593
Total Equity 1,471 1,048 281 100 201
Total Liabilities & Shareholder's Equity 3,233 2,668 1,323 912 948
Cash Flow 295 203 (26) (102) (106)
Working Capital 2,448 1,928 925 664 688
Free Cash Flow 309 585 136 (124) 9
Invested Capital 2,257 1,681 887 615 593
Shares Outstanding - Common Class Only 140 138 125 122 120
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 140 138 125 122 120
Total Common Shares Outstanding 140 138 125 122 120
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 140 132 124 121 120
Diluted Weighted Shares Outstanding 143 134 126 121 120